TOP - January 2023 Vol 16, No 1

TOP Jan. 2023 cover

A shortened course of radiation therapy is safe and effective for men with high-risk prostate cancer, according to the results of the phase 3 Prostate Cancer Study 5 (PCS5) trial.
This section provides a brief overview of new cancer drugs and new indications approved by the FDA between October 21, 2022, and December 1, 2022.
Page 2 of 2
Results 11 - 12 of 12